Nieuws

In een gesprek met Vogue deelt Serena Williams dat ze afslankmedicijn GLP-1 gebruikt. "Transparantie is voor mij belangrijk." ...
Serena Williams is opening up about her fitness journey, revealing that she uses the injectable GLP-1 weight loss drug ...
Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss drug.
Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...
In a candid conversation, tennis legend Serena Williams sheds light on her experience with GLP-1 medication, revealing her journey towards body positivity and health. As a mother of two and a 23-time ...
Serena Williams lost 31 pounds using Zepbound after traditional training failed, opening up about health, hormones, and her ...
GLP-1 meds are trending after Serena Williams’ 31-pound weight loss. A doctor breaks down the side effects, safety concerns & ...
" Afvalspuiten” zoals semaglutide ( Ozempic/Wegovy) en tirzepatide (Mounjaro/Zepbound) remmen honger en vertragen de ...
Investing.com - Guggenheim heeft woensdag het koersdoel voor Eli Lilly (NYSE:LLY) verlaagd naar $ 875,00 van $ 942,00, maar ...
Fabrikanten van afslankmedicijnen zullen naar verwachting tegen begin 2030 meer dan $150 miljard aan inkomsten binnenhalen, dankzij de toenemende populariteit van Eli Lilly’s Zepbound en Novo Nordisk’ ...
GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...
Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to ...